Annual FCF
-$31.85 M
-$3.51 M-12.40%
December 31, 2023
Summary
- As of February 7, 2025, TRVI annual free cash flow is -$31.85 million, with the most recent change of -$3.51 million (-12.40%) on December 31, 2023.
- During the last 3 years, TRVI annual FCF has fallen by -$2.81 million (-9.70%).
- TRVI annual FCF is now -298.69% below its all-time high of -$7.99 million, reached on December 31, 2017.
Performance
TRVI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$9.56 M
-$845.00 K-9.70%
September 30, 2024
Summary
- As of February 7, 2025, TRVI quarterly free cash flow is -$9.56 million, with the most recent change of -$845.00 thousand (-9.70%) on September 30, 2024.
- Over the past year, TRVI quarterly FCF has dropped by -$3.17 million (-49.76%).
- TRVI quarterly FCF is now -139.38% below its all-time high of -$3.99 million, reached on September 30, 2018.
Performance
TRVI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$35.12 M
-$2.26 M-6.88%
September 30, 2024
Summary
- As of February 7, 2025, TRVI TTM free cash flow is -$35.12 million, with the most recent change of -$2.26 million (-6.88%) on September 30, 2024.
- Over the past year, TRVI TTM FCF has dropped by -$3.27 million (-10.26%).
- TRVI TTM FCF is now -775.47% below its all-time high of -$4.01 million, reached on March 31, 2018.
Performance
TRVI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TRVI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.4% | -49.8% | -10.3% |
| 3 y3 years | -9.7% | -32.0% | -11.0% |
| 5 y5 years | -72.6% | -23.6% | -52.0% |
TRVI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.4% | at low | -54.7% | +8.7% | -31.3% | at low |
| 5 y | 5-year | -37.9% | at low | -104.5% | +8.7% | -52.0% | at low |
| alltime | all time | -298.7% | at low | -139.4% | +8.7% | -775.5% | at low |
Trevi Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.56 M(+9.7%) | -$35.12 M(+6.9%) |
| Jun 2024 | - | -$8.71 M(-16.8%) | -$32.86 M(-3.5%) |
| Mar 2024 | - | -$10.47 M(+64.0%) | -$34.06 M(+6.9%) |
| Dec 2023 | -$31.85 M(+12.4%) | -$6.38 M(-12.6%) | -$31.85 M(-0.2%) |
| Sep 2023 | - | -$7.30 M(-26.4%) | -$31.91 M(-4.0%) |
| Jun 2023 | - | -$9.91 M(+20.1%) | -$33.23 M(+12.7%) |
| Mar 2023 | - | -$8.25 M(+28.0%) | -$29.50 M(+4.1%) |
| Dec 2022 | -$28.33 M(-2.1%) | -$6.45 M(-25.2%) | -$28.33 M(+0.8%) |
| Sep 2022 | - | -$8.62 M(+39.6%) | -$28.12 M(+5.2%) |
| Jun 2022 | - | -$6.18 M(-12.9%) | -$26.74 M(-6.1%) |
| Mar 2022 | - | -$7.09 M(+13.9%) | -$28.46 M(-1.7%) |
| Dec 2021 | -$28.95 M | -$6.23 M(-14.0%) | -$28.95 M(-8.5%) |
| Sep 2021 | - | -$7.24 M(-8.3%) | -$31.65 M(+0.8%) |
| Jun 2021 | - | -$7.90 M(+4.2%) | -$31.39 M(-1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$7.58 M(-15.1%) | -$31.94 M(+10.0%) |
| Dec 2020 | -$29.03 M(+25.7%) | -$8.93 M(+27.9%) | -$29.03 M(+10.4%) |
| Sep 2020 | - | -$6.98 M(-17.4%) | -$26.30 M(-2.8%) |
| Jun 2020 | - | -$8.45 M(+80.8%) | -$27.06 M(+14.3%) |
| Mar 2020 | - | -$4.67 M(-24.7%) | -$23.67 M(+2.5%) |
| Dec 2019 | -$23.10 M(+25.2%) | -$6.20 M(-19.8%) | -$23.10 M(+6.3%) |
| Sep 2019 | - | -$7.73 M(+52.8%) | -$21.72 M(+20.8%) |
| Jun 2019 | - | -$5.06 M(+23.3%) | -$17.98 M(-3.0%) |
| Mar 2019 | - | -$4.11 M(-14.9%) | -$18.54 M(+0.5%) |
| Dec 2018 | -$18.45 M(+130.9%) | -$4.82 M(+20.8%) | -$18.45 M(+35.4%) |
| Sep 2018 | - | -$3.99 M(-29.0%) | -$13.62 M(+41.4%) |
| Jun 2018 | - | -$5.62 M(+40.1%) | -$9.63 M(+140.1%) |
| Mar 2018 | - | -$4.01 M | -$4.01 M |
| Dec 2017 | -$7.99 M | - | - |
FAQ
- What is Trevi Therapeutics annual free cash flow?
- What is the all time high annual FCF for Trevi Therapeutics?
- What is Trevi Therapeutics annual FCF year-on-year change?
- What is Trevi Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly FCF year-on-year change?
- What is Trevi Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Trevi Therapeutics?
- What is Trevi Therapeutics TTM FCF year-on-year change?
What is Trevi Therapeutics annual free cash flow?
The current annual FCF of TRVI is -$31.85 M
What is the all time high annual FCF for Trevi Therapeutics?
Trevi Therapeutics all-time high annual free cash flow is -$7.99 M
What is Trevi Therapeutics annual FCF year-on-year change?
Over the past year, TRVI annual free cash flow has changed by -$3.51 M (-12.40%)
What is Trevi Therapeutics quarterly free cash flow?
The current quarterly FCF of TRVI is -$9.56 M
What is the all time high quarterly FCF for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly free cash flow is -$3.99 M
What is Trevi Therapeutics quarterly FCF year-on-year change?
Over the past year, TRVI quarterly free cash flow has changed by -$3.17 M (-49.76%)
What is Trevi Therapeutics TTM free cash flow?
The current TTM FCF of TRVI is -$35.12 M
What is the all time high TTM FCF for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM free cash flow is -$4.01 M
What is Trevi Therapeutics TTM FCF year-on-year change?
Over the past year, TRVI TTM free cash flow has changed by -$3.27 M (-10.26%)